Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Will US, Europe work together on AI regulation?

Sundar Pichai, who serves as the CEO for both Alphabet and Google, wants the United States and European Union to work together on developing AI regulations.

 

Thumbnail

Savings impact of alternative payment models proves difficult to project

The Centers for Medicare & Medicaid Innovation savings projections keep moving, underscoring just how difficult it is to estimate the impact of untested alternative payment models, according to a recent analysis from Avalere Health.

Thumbnail

Largest physician specialty group endorses Medicare for all

The American College of Physicians, which represents 159,000 internists in the U.S., has endorsed a single-payer American healthcare system.

Thumbnail

Trump worries about healthcare poll, regrets enacting vaping restrictions

HHS Secretary Alex Azar took some heat from President Trump after a recent poll showed Democrats leading when it came to the issue of healthcare.

 

Thumbnail

Medical researchers must understand risks associated with AI

AI is poised to change the healthcare industry forever—but risks remain that researchers must take seriously.

Thumbnail

Hospital, health system model changes drove M&A in 2019

Changing models across hospitals and health systems helped drive mergers and acquisition activity in 2019, according to a new report from Kaufman Hall.

Thumbnail

Without individual mandate, the ACA chugs along

The Affordable Care Act has remained strong despite the lack of an individual mandate, which was effectively stripped in the 2018 budget by Republicans.

Thumbnail

UPMC designates $1B investment in life sciences

The innovation and venture capital arm of University of Pittsburgh Medical Center (UPMC) is planning to invest $1 billion into life sciences to develop new drugs, diagnostics and devices over the next four years.